Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP379952.RAZGNXHYgRfs3Bl8vALAhLxRY9Y4nB3i0RJ47f0A7CL2U130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP379952.RAZGNXHYgRfs3Bl8vALAhLxRY9Y4nB3i0RJ47f0A7CL2U130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP379952.RAZGNXHYgRfs3Bl8vALAhLxRY9Y4nB3i0RJ47f0A7CL2U130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP379952.RAZGNXHYgRfs3Bl8vALAhLxRY9Y4nB3i0RJ47f0A7CL2U130_provenance.
- NP379952.RAZGNXHYgRfs3Bl8vALAhLxRY9Y4nB3i0RJ47f0A7CL2U130_assertion description "[Furthermore and extending earlier findings using tzb-resistant cells, exogenously imposed autophagy inhibition increases the anticancer effect of trastuzumab on tzb-sensitive ERBB2-expressing breast tumor cells, indicating that pharmacological autophagy suppression has a wider role in the treatment of ERBB2-positive breast cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP379952.RAZGNXHYgRfs3Bl8vALAhLxRY9Y4nB3i0RJ47f0A7CL2U130_provenance.
- NP379952.RAZGNXHYgRfs3Bl8vALAhLxRY9Y4nB3i0RJ47f0A7CL2U130_assertion evidence source_evidence_literature NP379952.RAZGNXHYgRfs3Bl8vALAhLxRY9Y4nB3i0RJ47f0A7CL2U130_provenance.
- NP379952.RAZGNXHYgRfs3Bl8vALAhLxRY9Y4nB3i0RJ47f0A7CL2U130_assertion SIO_000772 24492513 NP379952.RAZGNXHYgRfs3Bl8vALAhLxRY9Y4nB3i0RJ47f0A7CL2U130_provenance.
- NP379952.RAZGNXHYgRfs3Bl8vALAhLxRY9Y4nB3i0RJ47f0A7CL2U130_assertion wasDerivedFrom befree-20150227 NP379952.RAZGNXHYgRfs3Bl8vALAhLxRY9Y4nB3i0RJ47f0A7CL2U130_provenance.
- NP379952.RAZGNXHYgRfs3Bl8vALAhLxRY9Y4nB3i0RJ47f0A7CL2U130_assertion wasGeneratedBy ECO_0000203 NP379952.RAZGNXHYgRfs3Bl8vALAhLxRY9Y4nB3i0RJ47f0A7CL2U130_provenance.
- befree-20150227 importedOn "2015-02-27" NP379952.RAZGNXHYgRfs3Bl8vALAhLxRY9Y4nB3i0RJ47f0A7CL2U130_provenance.